Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 6/20 | 0.49 |
| ▸ | LIPG | Q9Y5X9 | 6/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2768064 | 1.00 | LPL (0.49) | LPLLIPGKDM4E | |
| SCHEMBL119235 | 0.99 | LPL (0.50) | LPLLIPGKDM4E | |
| SCHEMBL12122383 | 0.90 | LPL (0.55) | LPLLIPGKDM4E | |
| SCHEMBL12276242 | 0.90 | LPL (0.55) | LPLLIPGKDM4E | |
| SCHEMBL13410397 | 0.90 | LPL (0.55) | LPLLIPGKDM4E | |
| SCHEMBL13410351 | 0.90 | LPL (0.55) | LPLLIPGKDM4E | |
| SCHEMBL1568941 | 0.89 | LPL (0.54) | LPLLIPG | |
| SCHEMBL16806600 | 0.85 | LPL (0.41) | LPLLIPG | |
| SCHEMBL13976523 | 0.84 | LPL (0.47) | LPLLIPG | |
| SCHEMBL2766961 | 0.83 | LPL (0.35) | LPLLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7199251-B2 | Process for the production of linear organic thiophene-phenylene oligomers | H.C. STARCK GMBH & CO. KG (DE) | 2007-04-03 | — | — | US | claimed |
| US-20050098777-A1 | Process for the production of linear organic thiophene-phenylene oligomers | H.C. STARCK GMBH (DE) | 2005-05-12 | — | — | US | claimed |
| EP-1531154-B1 | Process for the preparation of linear organic thiophene/phenylene oligomers | STRACK H C CLEVIOS GMBH (DE) | 2010-04-14 | — | — | EP | disclosed |
| EP-1531154-B1 | Process for the preparation of linear organic thiophene/phenylene oligomers | STRACK H C CLEVIOS GMBH (DE) | 2010-04-14 | — | — | EP | disclosed |
| EP-1867651-A1 | Semi-conducting coatings containing organic linear thiophen-phenyl oligomers | H.C. Starck GmbH (DE) | 2007-12-19 | — | — | EP | disclosed |
| EP-1867651-A1 | Semi-conducting coatings containing organic linear thiophen-phenyl oligomers | H.C. Starck GmbH (DE) | 2007-12-19 | — | — | EP | disclosed |
| US-7199251-B2 | Process for the production of linear organic thiophene-phenylene oligomers | H.C. STARCK GMBH & CO. KG (DE) | 2007-04-03 | — | — | US | disclosed |
| US-7199251-B2 | Process for the production of linear organic thiophene-phenylene oligomers | H.C. STARCK GMBH & CO. KG (DE) | 2007-04-03 | — | — | US | disclosed |
| US-7199251-B2 | Process for the production of linear organic thiophene-phenylene oligomers | H.C. STARCK GMBH & CO. KG (DE) | 2007-04-03 | — | — | US | disclosed |
| EP-1531154-A2 | Process for the preparation of linear organic thiophene/phenylene oligomers | H.C. Starck GmbH (DE) | 2005-05-18 | — | — | EP | disclosed |
| US-20050098777-A1 | Process for the production of linear organic thiophene-phenylene oligomers | H.C. STARCK GMBH (DE) | 2005-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050098777-A1 | Process for the production of linear organic thiophene-phenylene oligomers | TYR, TEC, TYRO3 | LPL 3616/4885LIPG 3551/4885KDM4E 2458/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.